Citius Pharmaceuticals CTXR
NASDAQ CTXR
$0.48 -0.01 (-2.48%)
As of: Nov 11, 2026 · 3:57 PM EST

Citius Pharmaceuticals (CTXR) Current Leases (2024 - 2026)

Updated

Analysis

Citius Pharmaceuticals (CTXR) Current Leases (2024 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Citius Pharmaceuticals 13.45 Mn -10.82 Mn 1.00 Mn 766,957.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 766,957.00
Mar 31, 2026 808,162.00
Dec 31, 2025 829,646.00
Sep 30, 2025 813,273.00
Jun 30, 2025 881,651.00
Mar 31, 2025 931,795.00
Dec 31, 2024 204,569.00
Sep 30, 2024 262,865.00
API Access

Citius Pharmaceuticals Current Leases API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=current-leases&ticker=CTXR&period=max&api_key=YOUR_API_KEY